More NewsRead More
Developing Novel Treatment for Condition that Affects 40 Percent of the Female Population
August 10, 2015
from Business Insider
Palatin Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
June 04, 2015
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015
May 13, 2015
"Female Viagra" seen more a pace-setter than moneymaker
August 19, 2015
Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction
February 20, 2015
UPDATE 2-U.S. FDA approves 'female Viagra' with strong warning
August 18, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here